blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3189053

EP3189053 - AN IMPROVED PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  11.03.2022
Database last updated on 25.09.2024
FormerThe patent has been granted
Status updated on  03.04.2021
FormerGrant of patent is intended
Status updated on  07.12.2020
FormerExamination is in progress
Status updated on  18.12.2019
FormerRequest for examination was made
Status updated on  15.06.2017
FormerThe international publication has been made
Status updated on  17.01.2017
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024 [2024/41]
Applicant(s)For all designated states
UNICHEM LABORATORIES LIMITED
Unichem Bhavan, Prabhat Estate
Off S. V. Road, Jogeshwari (West)
Mumbai, Maharashtra 400 102 / IN
[2017/28]
Inventor(s)01 / SATHE, Dhananjay G.
202/A-1
Golden Park
L.B.S. Marg
Panchpakhadi, Thane
Maharashtra 400601 / IN
02 / DAS, Arijit
25/1 Jyotish Roy Road
P.O: New Alipore
Kolkata West Bengal State 700053 / IN
03 / SURVE, Yashwant
2A/304 New Omkar Society
New MHADA Colony
Near NNP 1&2
Dindoshi, Goregaon (East)
Mumbai Maharashtra 400068 / IN
04 / AHIRE, Ramdas N.
At Post-Kusur
Taluka-Yeola
District-Nasik
Maharashtra 423401 / IN
 [2018/09]
Former [2017/28]01 / SATHE, Dhananjay D
202/A-1
Golden Park
L.B.S. Marg
Panchpakhadi, Thane
Maharashtra 400601 / IN
02 / DAS, Arijit
25/1 Jyotish Roy Road
P.O: New Alipore
Kolkata West Bengal State 700053 / IN
03 / SURVE, Yashwant
2A/304 New Omkar Society
New MHADA Colony
Near NNP 1&2
Dindoshi, Goregaon (East)
Mumbai Maharashtra 400068 / IN
04 / AHIRE, Ramdas N.
At Post-Kusur
Taluka-Yeola
District-Nasik
Maharashtra 423401 / IN
Representative(s)Laufhütte, Dieter
Lorenz Seidler Gossel
Rechtsanwälte Patentanwälte
Partnerschaft mbB
Widenmayerstraße 23
80538 München / DE
[2017/28]
Application number, filing date15837485.001.09.2015
[2017/28]
WO2015IB56630
Priority number, dateIN2014MUM283305.09.2014         Original published format: IN 2833MU2014
IN2015MUM269016.07.2015         Original published format: IN 2690MU2015
[2017/28]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2016035007
Date:10.03.2016
Language:EN
[2016/10]
Type: A2 Application without search report 
No.:EP3189053
Date:12.07.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 10.03.2016 takes the place of the publication of the European patent application.
[2017/28]
Type: B1 Patent specification 
No.:EP3189053
Date:05.05.2021
Language:EN
[2021/18]
Search report(s)International search report - published on:IN06.05.2016
(Supplementary) European search report - dispatched on:EP04.01.2018
ClassificationIPC:C07D471/04, C07D211/86
[2017/28]
CPC:
C07D471/04 (EP,US); C07D211/86 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/28]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
TitleGerman:VERBESSERTES VERFAHREN ZUR HERSTELLUNG VON APIXABAN UND ZWISCHENPRODUKTEN DAVON[2017/28]
English:AN IMPROVED PROCESS FOR THE PREPARATION OF APIXABAN AND INTERMEDIATES THEREOF[2017/28]
French:PROCÉDÉ AMÉLIORÉ POUR LA PRÉPARATION D'APIXABAN ET DE SES INTERMÉDIAIRES[2017/28]
Entry into regional phase17.01.2017National basic fee paid 
17.01.2017Search fee paid 
17.01.2017Designation fee(s) paid 
17.01.2017Examination fee paid 
Examination procedure17.01.2017Examination requested  [2017/28]
17.01.2017Date on which the examining division has become responsible
20.07.2018Amendment by applicant (claims and/or description)
02.01.2020Despatch of a communication from the examining division (Time limit: M06)
29.04.2020Reply to a communication from the examining division
08.12.2020Communication of intention to grant the patent
29.03.2021Fee for grant paid
29.03.2021Fee for publishing/printing paid
29.03.2021Receipt of the translation of the claim(s)
Opposition(s)08.02.2022No opposition filed within time limit [2022/15]
Fees paidRenewal fee
28.09.2017Renewal fee patent year 03
27.09.2018Renewal fee patent year 04
25.09.2019Renewal fee patent year 05
28.09.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU01.09.2015
AL05.05.2021
AT05.05.2021
CY05.05.2021
CZ05.05.2021
DK05.05.2021
EE05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
MK05.05.2021
MT05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IE01.09.2021
LU01.09.2021
IS05.09.2021
PT06.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
[2024/41]
Former [2024/22]HU01.09.2015
AL05.05.2021
AT05.05.2021
CY05.05.2021
CZ05.05.2021
DK05.05.2021
EE05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
MK05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IE01.09.2021
LU01.09.2021
IS05.09.2021
PT06.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
Former [2023/30]HU01.09.2015
AL05.05.2021
AT05.05.2021
CY05.05.2021
CZ05.05.2021
DK05.05.2021
EE05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IE01.09.2021
LU01.09.2021
IS05.09.2021
PT06.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
Former [2023/29]HU01.09.2015
AL05.05.2021
AT05.05.2021
CZ05.05.2021
DK05.05.2021
EE05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IE01.09.2021
LU01.09.2021
IS05.09.2021
PT06.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
Former [2022/37]AL05.05.2021
AT05.05.2021
CZ05.05.2021
DK05.05.2021
EE05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IE01.09.2021
LU01.09.2021
IS05.09.2021
PT06.09.2021
BE30.09.2021
CH30.09.2021
LI30.09.2021
Former [2022/35]AL05.05.2021
AT05.05.2021
CZ05.05.2021
DK05.05.2021
EE05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IE01.09.2021
LU01.09.2021
IS05.09.2021
PT06.09.2021
BE30.09.2021
Former [2022/34]AL05.05.2021
AT05.05.2021
CZ05.05.2021
DK05.05.2021
EE05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
LU01.09.2021
IS05.09.2021
PT06.09.2021
BE30.09.2021
Former [2022/29]AL05.05.2021
AT05.05.2021
CZ05.05.2021
DK05.05.2021
EE05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SI05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/25]AL05.05.2021
AT05.05.2021
CZ05.05.2021
DK05.05.2021
EE05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
MC05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/23]AT05.05.2021
CZ05.05.2021
DK05.05.2021
EE05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/10]AT05.05.2021
CZ05.05.2021
DK05.05.2021
EE05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
PT06.09.2021
IS22.12.2021
Former [2022/09]AT05.05.2021
CZ05.05.2021
DK05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RO05.05.2021
RS05.05.2021
SE05.05.2021
SK05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/08]AT05.05.2021
CZ05.05.2021
DK05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RS05.05.2021
SE05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/07]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RS05.05.2021
SE05.05.2021
SM05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2022/04]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
NL05.05.2021
PL05.05.2021
RS05.05.2021
SE05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2021/52]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
PL05.05.2021
RS05.05.2021
SE05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2021/51]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
RS05.05.2021
SE05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
IS05.09.2021
PT06.09.2021
Former [2021/50]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
SE05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
PT06.09.2021
Former [2021/49]AT05.05.2021
FI05.05.2021
HR05.05.2021
LT05.05.2021
LV05.05.2021
SE05.05.2021
BG05.08.2021
NO05.08.2021
GR06.08.2021
Former [2021/47]AT05.05.2021
FI05.05.2021
LT05.05.2021
BG05.08.2021
Former [2021/46]AT05.05.2021
FI05.05.2021
LT05.05.2021
Documents cited:Search[E]EP3029028  (SHANGHAI SYNCORES TECHNOLOGIES INC [CN], et al) [E] 4 * examples 5-8 *;
 [XI]  - Disclosed Anonymously, "SYNTHESIS OF A 5,6-DIHYDROPYRIDIN-2(1H)-ONE DERIVATIVE An IP.com Prior Art Database Technical Disclosure", (20131023), pages 1 - 3, URL: http://ip.com/IPCOM/000232170, (20171214), XP055435362 [X] 4 * Scheme 1 * [I] 3,5-15
 [A]  - N. R. AYYANGAR ET AL, "Catalytic Reduction of Nitroarenes with Hydrazine Hydrate in Suitable Solvents", SYNTHESIS, STUTTGART, DE., (19810101), doi:10.1055/s-1981-29557, ISSN 0039-7881, pages 640 - 643, XP055435802 [A] 3,5,6,9-11 * the whole document *

DOI:   http://dx.doi.org/10.1055/s-1981-29557
International search[Y]CN101967145  (UNIV EAST CHINA SCIENCE & TECH, et al) [Y] 1-17 * Page 8, scheme 4 *;
 [Y]CN103626689  (SHANGHAI INST PHARM INDUSTRY, et al) [Y] 1-17 * Claims *;
 [X]WO2014056434  (SUNSHINE LAKE PHARMA CO LTD [CN]) [X] 18-20 * Pages 14-17, examples 1-3, claim 10 *
by applicantUS6413980
 US6967208
 WO2012168364
 WO2007001385
 CN103626689
 US7396932
 CN101967145
 CN102675314
 WO2013119328
    - Synthetic communication, (20130000), vol. 43, pages 72 - 79
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.